Novel heparin entities and methods of use
作者： Nora Mardirosian , Roy Biran , Charles D. Claude , Mei Li , Paul D. Drumheller
DOI:
关键词:
摘要: The present invention relates to immobilized biologically active entities that retain a significant biological activity following manipulation. also comprises medical substrate comprising heparin entity bound onto via at least one molecule, wherein said is heparinase-1 sensitive.
google.com.au 参考文章(69)
Anthony C. Lunn, Stent and method of varying amounts of heparin coated thereon to control treatment ,(1996)
Robert J. Linhardt, Charles A. Hales, Hari G. Garg, Chemistry and biology of heparin and heparan sulfate Elsevier. ,(2005)
Robert W. Gore, Porous products and process therefor ,(1977)
Yasushi Joh, Non-thrombogenic material comprising substrate which has been reacted with heparin ,(1980)
Robert J. Linhardt, Masao Yafuso, Process to activate sulfated polysaccharides ,(1996)
Robert L. Cleek, Krzysztof R. Pietrzak, Michael D. Daly, Immobilized biologically active entities having a high degree of biological activity following sterilization ,(2006)
Michael D. Daly, Robert L. Cleek, Krzysztof R. Pietrzak, Immobilized biologically active entities having a high degree of biological activity following mecanical manipulation or sterilization ,(2007)
Shivpal Singh Sandhu, Ajay Kumar Luthra, Non-thrombogenic and anti-thrombogenic polymers ,(1997)
Robert L. Cleek, Krzysztof R. Pietrzak, Michael D. Daly, Immobilized biologically active entities having high biological activity following mechanical manipulation ,(2009)